The myth of mild asthma

Annals of Allergy, Asthma and Immunology

Volumn 89, Issue 4, 2002, Pages 340-343

  Stempel, David A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; SALBUTAMOL; TERBUTALINE;

ADOLESCENT; ASTHMA; CASE REPORT; DISEASE EXACERBATION; DISEASE SEVERITY; EDITORIAL; EXERCISE; FATALITY; FEMALE; HUMAN; INFLAMMATION; LUNG FUNCTION; MEDICAL DECISION MAKING; MEDICAL LITERATURE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SPIROMETRY; SYMPTOMATOLOGY;

EID: 0036825266     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62030-3     Document Type: Editorial

References (23)

1. Roberson CF, Rubinfeld AR, Bowes G. Pediatric asthma deaths in Victoria: the mild are at risk. Pediatr Pulmonol 1992;13: 95-100.
2. Burr ML, Davies BH, Hoare A, et al. A confidential inquiry into asthma deaths in Wales. Thorax 1999;54:985-989.
3. Hessel PA, Mitchell I, Tough S, et al. Risk factors for death from asthma. Ann Allergy Asthma Immunol 1999;83:362-368.
4. Haahtela T, Jarvinen M, Kava T, et al. Effects of reducing or discontinuing inhaled BUD in patients with mild asthma. N Engl J Med 1994;331:700-705.
5. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-381.
6. Selroos O, Pietinalho A, Lofroos AB, Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 1995;108:1228-1234.
7. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 1992;90:32-42.
8. Lim S, Jatakanon A, John M, et al. Effect of inhaled budesonide on lung function and airway inflammation: assessment by various inflammatory markers in mild asthma. Am J Respir Crit Care Med 1999;159:22-30.
9. Jónasson G, Carlsen K-H, Hultquist C. Low-dose budesonide improves exercise-induced bronchospasm in schoolchildren. Pediatr Allergy Immunol 2000;11:120-125.
10. Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000;343:1054-1063.
11. O'Byrne P, Cuddy L, Taylor W, et al. Efficacy and cost benefit of inhaled corticosteroids in patients considered to have mild asthma in a primary care practice. Can Respir J 1996;3: 169-175.
12. O'Bryne PM, Barnes PJ, Rodriguez-Roisin R, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: The OPTIMA randomized trial. Am J Respir Crit Care Med 2001;164:1392-1397.
13. Metso T, Kilpiö K, Björkstén F, et al. Detection and treatment of early asthma. Allergy 2000;55:505-509.
14. Kendrick AH, Higgs CM, Whitfield MJ, Laszlo G. Accuracy of perception of severity of asthma: patients treated in a general practice. BMJ 1993;307:422-424.
15. Preventative Services Task Force. Guide to Clinical Preventative Services: Report of the U. S. Preventative Services Task Force. 2nd ed. Baltimore, MD: Williams & Wilkins, 1996.
16. Concato J, Shah N, Horowitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1878-1886.
17. National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Expert panel report II. Guidelines for the diagnosis and management of asthma. Publication no 97-4051A. Bethesda, MD: US Department of Health and Human Services, 1997.
18. National Heart, Lung, and Blood Institute/World Health Organization. Global initiative for asthma: global strategy for asthma management and prevention: NHLBI/WHO Workshop report. Publication no 95-3659. Bethesda, MD: National Heart, Lung and Blood Institute, January 1995.
19. Martin RJ. Mechanisms of nocturnal asthma. In: Busse WW, Holgate ST, editors. Asthma and Rhinitis. Cambridge, MA: Blackwell Science, 1995:1440-1452.
20. Colice GL, Burgt JV, Song J, et al. Categorizing asthma severity. Am J Respir Crit Care Med 1999;160:1962-1967.
21. Asthma in America: Executive Summary. Research Triangle Park, NC: Glaxo Wellcome, December 1998.
22. Suissa S, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001;107: 937-944.
23. Centers for Disease Control and Prevention. Forecasted statespecific estimates of self-reported asthma prevalence-United States, 1998. MMWR Morb Mortal Wkly Rep 1998;47: 1002-1025.